# AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

> Research article (Blood, 2023) · cited 16× · AI/ML

**Wikidata**: [openalex:W4389234952](https://www.wikidata.org/wiki/openalex:W4389234952)  
**Source**: https://4ort.xyz/entity/ahod2131-a-randomized-phase-3-response-adapted-trial-comparing-standard-therapy-with-immuno-oncology-therapy-for-childre